European Medicines Agency validates submission of MAA for Nidlegy

Nidlegy is partnered with Sun Pharma for the treatment of Skin Cancers in Europe, New Zealand and Australia. Both companies jointly made the following announcements:

- 23 October 2023 - Phase III PIVOTAL trial met the primary endpoint